Greykasell Wealth Strategies, Inc.
Position in GILD — Gilead Sciences, Inc.
CIK 2041220
DANVILLE, CA
Position in GILD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$204,923
-$4,132 QoQ
Shares Held
1,622
+8.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,905
of 2,266 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Greykasell Wealth Strategies, Inc. holds $4,734,430 across 12 Drug Manufacturers - General names. GILD ranks #6 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
5,664 | $1,425,288 | |
| 2 | AMGN |
Amgen Inc
|
3,119 | $1,129,452 | |
| 3 | JNJ |
Johnson & Johnson
|
3,163 | $803,307 | |
| 4 | LLY |
ELI LILLY & Co
|
381 | $456,982 | |
| 5 | NVS |
Novartis AG
|
2,013 | $315,477 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
1,622 | $204,923 | |
| 7 | AZN |
Astrazeneca PLC
|
690 | $130,837 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,848 | $106,481 |
All Filings in GILD
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $204,923 | 1,622 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $209,055 | 1,500 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $227,191 | 1,851 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $228,660 | 2,060 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $169,409 | 1,528 | Shares | Sole | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||